Is CCRIS 3922 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use CCRIS 3922? Is CCRIS 3922 safe for nursing mother and child? Does CCRIS 3922 extracts into breast milk? Does CCRIS 3922 has any long term or short term side effects on infants? Can CCRIS 3922 influence milk supply or can CCRIS 3922 decrease milk supply in lactating mothers?

• DrLact safety Score for CCRIS 3922 is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of CCRIS 3922 may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that CCRIS 3922 may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using CCRIS 3922 .
• It is recommended to evaluate the advantage of not breastfeeding while using CCRIS 3922 Vs not using CCRIS 3922 And continue breastfeeding.
• While using CCRIS 3922 Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Stupor, flatulence or vomiting have been described. Theoretical risk though never reported of bone marrow toxicity. Use only if necessary. Avoid any use during neonatal period. Be aware of the possibility of false negative results of bacterial cultures when the mother is on antibiotics.

Adverse reactions such as vomiting, excessive intestinal gas and falling asleep at the breast have been reported in breastfed infants whose mothers were taking oral CCRIS 3922. Milk concentrations are not sufficient to induce "gray baby" syndrome, but since CCRIS 3922-induced aplastic anemia is not dose-related, this might occur, but has not been reported. An alternate drug is preferred to CCRIS 3922 during breastfeeding, especially while nursing a newborn or preterm infant. If the mother must receive CCRIS 3922 during nursing, monitor the infant for gastrointestinal disturbances and adequacy of nursing. Monitoring of the infant's complete blood count and differential is advisable. In some cases, discontinuation of breastfeeding might be preferred.

One study reported 50 breastfed infants whose mothers were give oral CCRIS 3922 beginning 2 to 12 days postpartum in dosages of 1 (n = 20), 2 (n = 20)or 3 grams (n = 10) daily. All of the infants refused to suck, and 50 to 60% fell asleep during nursing. Vomiting occurred after feeding in 10%, 25%, and 90% of infants with daily maternal dosages of 1, 2 and 3 grams, respectively. All infants had excessive intestinal gas and abdominal distention, with severe problems in 0.5%, 20% and 100% of infants with daily maternal dosages of 1, 2 and 3 grams, respectively.[4]